InvestorsHub Logo
Post# of 253509
Next 10
Followers 839
Posts 120655
Boards Moderated 13
Alias Born 09/05/2002

Re: masterlongevity post# 150291

Wednesday, 10/10/2012 1:25:34 PM

Wednesday, October 10, 2012 1:25:34 PM

Post# of 253509
Three drugs selected for AD-prevention trial are Gantenerumab, Solanezumab, and LY2886721 (a BACE inhibitor):

https://news.wustl.edu/news/Pages/24400.aspx

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.